These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14794919)

  • 1. Persistence of antibodies in human subjects injected with pneumococcal polysaccharides.
    HEIDELBERGER M; DILAPI MM; SIEGEL M; WALTER AW
    J Immunol; 1950 Nov; 65(5):535-41. PubMed ID: 14794919
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between the specificity of antibodies to pneumococcal polysaccharides S3 and S8 and the induced S3- and S8-depolymerases of Bacillus palustris.
    CAMPBELL JH; PAPPENHEIMER AM
    Ann N Y Acad Sci; 1963 May; 103():1014-26. PubMed ID: 14018138
    [No Abstract]   [Full Text] [Related]  

  • 3. Infrared spectra of pneumococcal polysaccharides.
    STEVENSON HJ; LEVINE S
    Science; 1952 Dec; 116(3026):705-6. PubMed ID: 13028251
    [No Abstract]   [Full Text] [Related]  

  • 4. THE PNEUMOCOCCAL POLYSACCHARIDES.
    HOW MJ; BRIMACOMBE JS; STACEY M
    Adv Carbohydr Chem; 1964; 19():303-58. PubMed ID: 14272331
    [No Abstract]   [Full Text] [Related]  

  • 5. The cross-reactivity of ketha gum and pneumococcal type I--short cut to a constituent of a polysaccharide.
    HEIDELBERGER M; TYLER JM; MUKHERJEE S
    Immunology; 1962 Nov; 5(6):666-72. PubMed ID: 13953335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of pneumococcal polysaccharides S3 and S8 by inducible depolymerases from Bacillus palustris.
    TORRIANI A; PAPPENHEIMER AM
    Bull Soc Chim Biol (Paris); 1960; 42():1619-26. PubMed ID: 13777587
    [No Abstract]   [Full Text] [Related]  

  • 7. A BIOASSAY FOR ESTIMATION OF PNEUMOCOCCAL POLYSACCHARIDE IN UNRESPONSIVE (PARALYZED) MICE.
    SISKIND GW; PATERSON PY
    J Immunol; 1964 Sep; 93():489-94. PubMed ID: 14218610
    [No Abstract]   [Full Text] [Related]  

  • 8. MECHANISMS OF IMMUNOLOGIC PARALYSIS BY PNEUMOCOCCAL POLYSACCHARIDE. IV. COMPARISON OF POLYSACCHARIDE AND WHOLE ORGANISMS.
    NEEPER CA; SEASTONE CV
    J Immunol; 1964 Nov; 93():867-71. PubMed ID: 14239947
    [No Abstract]   [Full Text] [Related]  

  • 9. INDUCTION OF UNRESPONSIVENESS AND IMMUNITY IN NEWBORN AND ADULT MICE WITH PNEUMOCOCCAL POLYSACCHARIDE.
    SISKIND GW; PATERSON PY; THOMAS L
    J Immunol; 1963 Jun; 90():929-34. PubMed ID: 14050203
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies in bacterial allergy. VI. Hapten aerosol desensitization of guinea pigs passively sensitized to specific pneumococcal polysaccharides.
    SWINEFORD O
    J Allergy; 1954 May; 25(3):260-9. PubMed ID: 13151799
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
    Väkeväinen M; Eklund C; Eskola J; Käyhty H
    J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MECHANISMS OF IMMUNOLOGIC PARALYSIS BY PNEUMOCOCCAL POLYSACCHARIDE. 3. IMMUNOLOGIC PARALYSIS IN RELATION TO MATURATION OF THE IMMUNOLOGIC RESPONSE OF MICE.
    NEEPER CA
    J Immunol; 1964 Nov; 93():860-6. PubMed ID: 14239946
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia.
    Andrade DC; Borges IC; Adrian PV; Meinke A; Barral A; Ruuskanen O; Käyhty H; Nascimento-Carvalho CM
    Pediatr Infect Dis J; 2016 Jun; 35(6):683-9. PubMed ID: 26954601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides.
    Denoël P; Godfroid F; Hermand P; Verlant V; Poolman J
    Vaccine; 2011 Sep; 29(38):6451-3. PubMed ID: 21315695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine.
    Nguyen JT; Myers N; Palaia J; Georgopoulos A; Rubins JB; Janoff EN
    Transl Res; 2007 Sep; 150(3):172-9. PubMed ID: 17761370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic potency in man of the specific polysaccharides of types I and V pneumococcus and their products of alkaline degradation.
    HEIDELBERGER M; MacLEOD CM; DILAPI MM
    J Immunol; 1951 Feb; 66(2):145-9. PubMed ID: 14814298
    [No Abstract]   [Full Text] [Related]  

  • 17. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
    Barrett DJ; Ayoub EM
    Clin Exp Immunol; 1986 Jan; 63(1):127-34. PubMed ID: 3955880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.
    Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM
    Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Homing Potentials of Streptococcus pneumoniae-Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations.
    Palkola NV; Pakkanen SH; Kantele JM; Pakarinen L; Puohiniemi R; Kantele A
    J Infect Dis; 2015 Oct; 212(8):1279-87. PubMed ID: 25838267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of C-polysaccharide in Streptococcus pneumoniae polysaccharides by high-performance anion-exchange chromatography with pulsed amperometric detection.
    Talaga P; Moreau M
    Dev Biol (Basel); 2000; 103():27-34. PubMed ID: 11214250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.